TrialPediatrics international : official journal of the Japan Pediatric Society

Azilsartan as an antihypertensive treatment in Japanese children under 6 years old: A phase 3 open-label long-term study.

Shuichi Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.